BIOCRYST PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Payable
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Increase (Decrease) in Accounts Payable of -$55.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $5.07M, a 83.37% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$60.40M.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $35.36M, a 73.33% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $24.58M, a 33.50% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in accounts payable for fiscal 2025 was $57.80M, a 291.19% increase from fiscal 2024.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in accounts payable for fiscal 2024 was $14.78M, a 17.92% increase from fiscal 2023.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in accounts payable for fiscal 2023 was $12.53M.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in accounts payable for fiscal 2022 was -$22.36M, a 156.73% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$55.33M 10-Q · filed 2026-08-05 | -$19.97M derived: sum of 3 quarters · filed 2026-08-05 | $4.61M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$60.40M 10-Q · filed 2026-05-06 | -$25.03M derived: sum of 2 quarters · filed 2026-05-06 | -$458.00K derived: sum of 3 quarters · filed 2026-05-06 | $30.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $35.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $59.94M derived: sum of 2 quarters · filed 2026-02-26 | $90.40M derived: sum of 3 quarters · filed 2026-08-05 | $57.80M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $24.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $55.03M derived: sum of 2 quarters · filed 2026-08-05 | $22.44M 10-Q · filed 2025-11-04 | $42.84M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $30.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$2.13M 10-Q · filed 2026-08-05 | $18.27M derived: sum of 3 quarters · filed 2026-08-05 | $36.67M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | -$32.59M 10-Q · filed 2026-05-06 | -$47.14M 10-Q · filed 2025-05-06 | -$12.19M derived: sum of 2 quarters · filed 2026-05-06 | $6.22M derived: sum of 3 quarters · filed 2026-05-06 | $26.75M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $20.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $38.81M derived: sum of 2 quarters · filed 2026-02-26 | $59.34M derived: sum of 3 quarters · filed 2026-02-26 | $14.78M 10-K · filed 2026-02-26 | -$62.38M 10-K · filed 2025-02-25 | |||
| 2024-09-30 | $18.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $38.94M derived: sum of 2 quarters · filed 2025-11-04 | -$5.63M 10-Q · filed 2025-11-04 | -$59.93M 10-Q · filed 2024-11-05 | $43.58M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | $20.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$24.03M 10-Q · filed 2025-08-05 | -$57.10M 10-Q · filed 2024-08-06 | $25.18M derived: sum of 3 quarters · filed 2026-02-26 | $15.91M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | -$44.57M 10-Q · filed 2025-05-06 | $4.64M derived: sum of 2 quarters · filed 2026-02-26 | -$4.62M derived: sum of 3 quarters · filed 2026-02-26 | -$4.81M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $49.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $39.95M derived: sum of 2 quarters · filed 2026-02-26 | $39.76M derived: sum of 3 quarters · filed 2026-02-26 | $12.53M 10-K · filed 2026-02-26 | -$16.81M 10-K · filed 2024-02-27 | |||
| 2023-09-30 | -$9.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$9.45M derived: sum of 2 quarters · filed 2024-11-05 | -$36.68M 10-Q · filed 2024-11-05 | -$31.40M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | -$188.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$27.41M 10-Q · filed 2024-08-06 | -$22.14M derived: sum of 3 quarters · filed 2025-02-25 | -$41.31M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | -$27.23M 10-Q · filed 2024-05-07 | -$21.95M derived: sum of 2 quarters · filed 2025-02-25 | -$41.12M derived: sum of 3 quarters · filed 2025-02-25 | -$26.68M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $5.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$13.90M derived: sum of 2 quarters · filed 2025-02-25 | $548.00K derived: sum of 3 quarters · filed 2025-02-25 | -$22.36M 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | -$19.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$4.73M derived: sum of 2 quarters · filed 2023-11-08 | -$27.64M 10-Q · filed 2023-11-08 | -$4.92M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-06-30 | $14.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$8.46M 10-Q · filed 2023-08-07 | $14.26M derived: sum of 3 quarters · filed 2024-02-27 | $28.21M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-03-31 | -$22.91M 10-Q · filed 2023-05-08 | -$188.00K derived: sum of 2 quarters · filed 2024-02-27 | $13.76M derived: sum of 3 quarters · filed 2024-02-27 | $23.88M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | $22.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $36.67M derived: sum of 2 quarters · filed 2024-02-27 | $46.78M derived: sum of 3 quarters · filed 2024-02-27 | $39.41M 10-K · filed 2024-02-27 | ||||
| 2021-09-30 | $13.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $24.07M derived: sum of 2 quarters · filed 2022-11-04 | $16.69M 10-Q · filed 2022-11-04 | $27.32M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | $10.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $2.74M 10-Q · filed 2022-08-05 | $13.37M derived: sum of 3 quarters · filed 2023-02-27 | $21.25M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | -$7.37M 10-Q · filed 2022-05-09 | $3.26M derived: sum of 2 quarters · filed 2023-02-27 | $11.14M derived: sum of 3 quarters · filed 2023-02-27 | $15.08M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | $10.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $18.51M derived: sum of 2 quarters · filed 2023-02-27 | $22.45M derived: sum of 3 quarters · filed 2023-02-27 | $17.36M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | $7.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $11.82M derived: sum of 2 quarters · filed 2021-11-04 | $6.72M 10-Q · filed 2021-11-04 | $8.49M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | $3.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$1.16M 10-Q · filed 2021-08-09 | $610.00K derived: sum of 3 quarters · filed 2022-02-28 | $8.01M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | -$5.10M 10-Q · filed 2021-05-07 | -$3.33M derived: sum of 2 quarters · filed 2022-02-28 | $4.06M derived: sum of 3 quarters · filed 2022-02-28 | $8.07M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $9.16M derived: sum of 2 quarters · filed 2022-02-28 | $13.17M derived: sum of 3 quarters · filed 2022-02-28 | $11.74M 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $7.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $11.40M derived: sum of 2 quarters · filed 2020-11-06 | $9.97M 10-Q · filed 2020-11-06 | $10.52M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $4.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $2.58M 10-Q · filed 2020-08-07 | $3.12M derived: sum of 3 quarters · filed 2021-03-01 | $2.62M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | -$1.43M 10-Q · filed 2020-05-11 | -$889.00K derived: sum of 2 quarters · filed 2021-03-01 | -$1.39M derived: sum of 3 quarters · filed 2021-03-01 | $2.91M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $540.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $40.00K derived: sum of 2 quarters · filed 2021-03-01 | $4.33M derived: sum of 3 quarters · filed 2021-03-01 | $4.49M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | -$500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $3.79M derived: sum of 2 quarters · filed 2019-11-08 | $3.95M 10-Q · filed 2019-11-08 | $6.49M derived: sum of 4 quarters · filed 2020-03-13 | ||||
| 2018-06-30 | $4.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $4.45M 10-Q · filed 2019-08-08 | $6.99M derived: sum of 3 quarters · filed 2020-03-13 | $9.26M derived: sum of 4 quarters · filed 2020-03-13 | ||||
| 2018-03-31 | $152.00K 10-Q · filed 2019-05-09 | $2.69M derived: sum of 2 quarters · filed 2020-03-13 | $4.97M derived: sum of 3 quarters · filed 2020-03-13 | $2.35M derived: sum of 4 quarters · filed 2020-03-13 | ||||
| 2017-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $4.82M derived: sum of 2 quarters · filed 2020-03-13 | $2.20M derived: sum of 3 quarters · filed 2020-03-13 | $3.84M 10-K · filed 2020-03-13 | ||||
| 2017-09-30 | $2.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$339.00K derived: sum of 2 quarters · filed 2018-11-08 | $1.30M 10-Q · filed 2018-11-08 | $2.85M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2017-06-30 | -$2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$975.00K 10-Q · filed 2018-08-09 | $567.00K derived: sum of 3 quarters · filed 2019-03-14 | -$2.76M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2017-03-31 | $1.64M 10-Q · filed 2018-05-09 | $3.18M derived: sum of 2 quarters · filed 2019-03-14 | -$140.00K derived: sum of 3 quarters · filed 2019-03-14 | -$8.34M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2016-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$1.78M derived: sum of 2 quarters · filed 2019-03-14 | -$9.98M derived: sum of 3 quarters · filed 2019-03-14 | -$10.52M 10-K · filed 2019-03-14 | ||||
| 2016-09-30 | -$3.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$11.53M derived: sum of 2 quarters · filed 2017-11-08 | -$12.07M 10-Q · filed 2017-11-08 | -$10.97M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-06-30 | -$8.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$8.74M 10-Q · filed 2017-08-08 | -$7.65M derived: sum of 3 quarters · filed 2018-03-12 | -$3.68M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-03-31 | -$541.00K 10-Q · filed 2017-05-08 | $553.00K derived: sum of 2 quarters · filed 2018-03-12 | $4.52M derived: sum of 3 quarters · filed 2018-03-12 | $9.73M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2015-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $5.06M derived: sum of 2 quarters · filed 2018-03-12 | $10.27M derived: sum of 3 quarters · filed 2018-03-12 | $13.68M 10-K · filed 2018-03-12 | $14.39M 10-K · filed 2016-02-26 | |||
| 2015-09-30 | $3.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $9.18M derived: sum of 2 quarters · filed 2016-11-08 | $12.58M 10-Q · filed 2016-11-08 | $13.64M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $5.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $8.61M 10-Q · filed 2016-08-08 | $9.67M derived: sum of 3 quarters · filed 2017-02-27 | $13.52M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $3.40M 10-Q · filed 2016-05-09 | $4.46M derived: sum of 2 quarters · filed 2017-02-27 | $8.31M derived: sum of 3 quarters · filed 2017-02-27 | |||||
| 2014-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $4.90M derived: sum of 2 quarters · filed 2017-02-27 | $4.66M 10-K · filed 2017-02-27 | $6.82M 10-K · filed 2016-02-26 | ||||
| 2014-09-30 | $3.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $3.60M 10-Q · filed 2015-11-06 | ||||||
| 2014-06-30 | -$247.00K 10-Q · filed 2015-08-07 | |||||||
| 2013-12-31 | -$2.05M 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |